GoAI
Get started
Elevance Health Inc. logo

Elevance Health Inc.

ELV

NYSEHealthcareMedical - Healthcare Plans

Open in GoAI

Previous close

$400.54

+$4.26 · +1.07%

Aug 21, 4:00 PM ET

Pre-market

$400

−$0.54 · -0.13%

Aug 24, 8:29 AM ET

ELV company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

79

Undervalued

Momentum

55

Neutral

Sentiment

73

Bullish

Risk resilience

77

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.

Industry
Medical - Healthcare Plans
Sector
Healthcare
Headquarters
US
CEO
Gail Koziara Boudreaux
Listed since
Oct 30, 2001
Employees
96,615

Market position

Day range

Current $400.54

52-week range

Current $400.54

Open
$396.96
Previous close
$396.28
Volume
771.53K
0.49× average
Average volume
1.58M
Average daily volume
Market cap
86.86B USD
Beta
0.69
Market reference 1
50-day average
$394.74
+1.47% above average
200-day average
$355.16
+12.78% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
101.5B USD
P/E (TTM)
17.8×
P/B (TTM)
1.94×
P/S (TTM)
0.43×
EV / EBITDA
10.51×
Earnings yield
7.28%
Free cash flow yield
4.08%
Dividend yield
1.71%

Profitability & efficiency

Gross margin
38.95%
Operating margin
3.51%
Net margin
2.47%
Return on equity
12.90%
Return on assets
4.66%
Return on invested capital
6.65%

Financial health

Debt / equity
0.69×
Current ratio
1.24×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends30%20%10%0%Gross margin, FY2021: 25.96%Gross margin, FY2022: 25.51%Gross margin, FY2023: 27.44%Gross margin, FY2024: 27.85%Gross margin, FY2025: 25.56%Operating margin, FY2021: 6.45%Operating margin, FY2022: 5.40%Operating margin, FY2023: 5.10%Operating margin, FY2024: 5.03%Operating margin, FY2025: 4.07%Net margin, FY2021: 4.40%Net margin, FY2022: 3.76%Net margin, FY2023: 3.49%Net margin, FY2024: 3.38%Net margin, FY2025: 2.84%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 25.96%. Gross margin FY2022 25.51%. Gross margin FY2023 27.44%. Gross margin FY2024 27.85%. Gross margin FY2025 25.56%. Operating margin FY2021 6.45%. Operating margin FY2022 5.40%. Operating margin FY2023 5.10%. Operating margin FY2024 5.03%. Operating margin FY2025 4.07%. Net margin FY2021 4.40%. Net margin FY2022 3.76%. Net margin FY2023 3.49%. Net margin FY2024 3.38%. Net margin FY2025 2.84%.

Income trends

Revenue

199.13B USD+12.62%

Operating income

8.11B USD-8.73%

Net income

5.66B USD-5.32%
Income trends across reported periods218.47B USD141.09B USD63.7B USD−13.68B USDRevenue, FY2021: 138.64B USDRevenue, FY2022: 156.6B USDRevenue, FY2023: 171.34B USDRevenue, FY2024: 176.81B USDRevenue, FY2025: 199.13B USDOperating income, FY2021: 8.95B USDOperating income, FY2022: 8.45B USDOperating income, FY2023: 8.75B USDOperating income, FY2024: 8.89B USDOperating income, FY2025: 8.11B USDNet income, FY2021: 6.1B USDNet income, FY2022: 5.89B USDNet income, FY2023: 5.99B USDNet income, FY2024: 5.98B USDNet income, FY2025: 5.66B USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 138.64B USD. Revenue FY2022 156.6B USD. Revenue FY2023 171.34B USD. Revenue FY2024 176.81B USD. Revenue FY2025 199.13B USD. Operating income FY2021 8.95B USD. Operating income FY2022 8.45B USD. Operating income FY2023 8.75B USD. Operating income FY2024 8.89B USD. Operating income FY2025 8.11B USD. Net income FY2021 6.1B USD. Net income FY2022 5.89B USD. Net income FY2023 5.99B USD. Net income FY2024 5.98B USD. Net income FY2025 5.66B USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue199.13B USD176.81B USD171.34B USD156.6B USD138.64B USD
Cost of goods sold148.22B USD127.57B USD124.33B USD116.64B USD102.65B USD
Gross profit50.9B USD49.24B USD47.01B USD39.95B USD35.99B USD
Operating expenses42.79B USD40.36B USD38.27B USD31.5B USD27.05B USD
Interest expense1.4B USD1.19B USD1.03B USD851M USD798M USD
Depreciation and amortization1.55B USD1.39B USD1.75B USD1.68B USD1.3B USD
Operating income8.11B USD8.89B USD8.75B USD8.45B USD8.95B USD
Net income5.66B USD5.98B USD5.99B USD5.89B USD6.1B USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
82%
9 beats, 2 misses, 0 met estimates
Average EPS surprise
+5.56%
11 comparable reports
Latest EPS result
7.45
Estimate 6.21 · Beat by 19.97%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates13.349.776.22.64Q1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Jan 23, 2025: actual 3.84, estimate 3.8, surprise +1.05%, Beat. Q2 2025, reported Apr 22, 2025: actual 11.97, estimate 11.41, surprise +4.91%, Beat. Q3 2025, reported Jul 17, 2025: actual 8.84, estimate 8.91, surprise -0.79%, Miss. Q4 2025, reported Oct 21, 2025: actual 6.03, estimate 4.93, surprise +22.31%, Beat. Q1 2026, reported Jan 28, 2026: actual 3.33, estimate 3.1, surprise +7.42%, Beat. Q2 2026, reported Apr 22, 2026: actual 12.58, estimate 10.82, surprise +16.27%, Beat. Q3 2026, reported Jul 15, 2026: actual 7.45, estimate 6.21, surprise +19.97%, Beat. Q4 2026, reported Oct 21, 2026: actual —, estimate 4.7, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates52.09B49.04B46B42.95BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Jan 23, 2025: actual 45.44B USD, estimate 44.95B USD, surprise +1.09%, Beat. Q2 2025, reported Apr 22, 2025: actual 48.77B USD, estimate 46.3B USD, surprise +5.32%, Beat. Q3 2025, reported Jul 17, 2025: actual 49.42B USD, estimate 48.19B USD, surprise +2.55%, Beat. Q4 2025, reported Oct 21, 2025: actual 50.09B USD, estimate 49.38B USD, surprise +1.43%, Beat. Q1 2026, reported Jan 28, 2026: actual 49.31B USD, estimate 49.84B USD, surprise -1.07%, Miss. Q2 2026, reported Apr 22, 2026: actual 49.49B USD, estimate 48.2B USD, surprise +2.68%, Beat. Q3 2026, reported Jul 15, 2026: actual 49.83B USD, estimate 48.88B USD, surprise +1.94%, Beat. Q4 2026, reported Oct 21, 2026: actual —, estimate 49.3B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$444.06

10.87% upside
Past 12 months12-month forecastHigh $498Average $444.06Low $391

Rating distribution

38 ratings
Strong buy00%
Buy2771%
Hold1129%
Sell00%
Strong sell00%

Recent analyst actions

12 institutions

ELV news

defenseworld.net

Barrow Hanley Mewhinney & Strauss LLC Takes $175.05 Million Position in Elevance Health, Inc. $ELV

Barrow Hanley Mewhinney and Strauss LLC purchased a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange…

Read source
defenseworld.net

31,408 Shares in Elevance Health, Inc. $ELV Acquired by B. Metzler seel. Sohn & Co. AG

B. Metzler seel. Sohn and Co. AG purchased a new position in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The…

Read source
defenseworld.net

Asahi Life Asset Management CO. LTD. Buys Shares of 1,279 Elevance Health, Inc. $ELV

Asahi Life Asset Management CO. LTD. purchased a new stake in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The…

Read source
defenseworld.net

Barden Capital Management Inc. Purchases New Stake in Elevance Health, Inc. $ELV

Barden Capital Management Inc. acquired a new position in Elevance Health, Inc. (NYSE: ELV) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC).…

Read source
defenseworld.net

1,633 Shares in Elevance Health, Inc. $ELV Acquired by Avise Financial Cooperative Inc.

Avise Financial Cooperative Inc. acquired a new stake in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,633…

Read source
zacks.com

Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?

Read source

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$6.84

2025 complete year+51.3% since 2021

2026 partial: $3.44

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 10, 2026

$1.72

Quarterly

Record Sep 10, 2026 · Payment Sep 25, 2026

Dividend

Ex-dividend Jun 10, 2026

$1.72

Quarterly

Record Jun 10, 2026 · Payment Jun 25, 2026

Dividend

Ex-dividend Mar 10, 2026

$1.72

Quarterly

Record Mar 10, 2026 · Payment Mar 25, 2026

Dividend

Ex-dividend Dec 5, 2025

$1.71

Quarterly

Record Dec 5, 2025 · Payment Dec 19, 2025

Dividend

Ex-dividend Sep 10, 2025

$1.71

Quarterly

Record Sep 10, 2025 · Payment Sep 25, 2025

Dividend

Ex-dividend Jun 10, 2025

$1.71

Quarterly

Record Jun 10, 2025 · Payment Jun 25, 2025

ELV peers

Eli Lilly and Company logo

LLY

Eli Lilly and Company

$1,254.77

+0.83%

Johnson & Johnson logo

JNJ

Johnson & Johnson

$270.24

+1.07%

AbbVie Inc. logo

ABBV

AbbVie Inc.

$265.01

+1.21%

Merck & Co., Inc. logo

MRK

Merck & Co., Inc.

$152.55

+2.39%

UnitedHealth Group Incorporated logo

UNH

UnitedHealth Group Incorporated

$390.11

+1.37%

Novartis AG logo

NVS

Novartis AG

$158.86

+1.68%

ETFs holding ELV

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
2.58B
Weight
0.11%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard S&P 500 ETF logoVanguard S&P 500 ETFVOO
Market value
2.12B
Weight
0.13%
AUM
1.7T USD
Expense ratio
0.03%
Price / 1D
$703.71+0.39%
State Street SPDR S&P 500 ETF logoState Street SPDR S&P 500 ETFSPY
Market value
1.07B
Weight
0.13%
AUM
817.87B USD
Expense ratio
0.09%
Price / 1D
$765.72+0.41%
Vanguard Morningstar Value ETF logoVanguard Morningstar Value ETFVTV
Market value
760.78M
Weight
0.30%
AUM
256.5B USD
Expense ratio
0.03%
Price / 1D
$226.4+0.54%
State Street Health Care Select Sector SPDR ETF logoState Street Health Care Select Sector SPDR ETFXLV
Market value
619.03M
Weight
1.38%
AUM
44.76B USD
Expense ratio
0.08%
Price / 1D
$174.62+1.29%
Vanguard Dividend Appreciation ETF logoVanguard Dividend Appreciation ETFVIG
Market value
451.74M
Weight
0.34%
AUM
130.9B USD
Expense ratio
0.04%
Price / 1D
$243.91+0.69%
Vanguard High Dividend Yield ETF logoVanguard High Dividend Yield ETFVYM
Market value
321.47M
Weight
0.32%
AUM
99.2B USD
Expense ratio
0.04%
Price / 1D
$164.97+0.59%
Vanguard Health Care ETF logoVanguard Health Care ETFVHT
Market value
245.46M
Weight
1.17%
AUM
20.9B USD
Expense ratio
0.09%
Price / 1D
$327.7+1.24%

Continue in GoAI

Research ELV

research.disclaimer